8329 — Shenzhen Neptunus Interlong Bio-technique Co Share Price
0.000.00%
Last trade - 00:00- HK$570.52m
- HK$372.42m
- CNY1.06bn
- 66
- 88
- 89
- 95
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.58 | ||
| Price to Tang. Book | 0.72 | ||
| Price to Free Cashflow | 5.09 | ||
| Price to Sales | 0.52 | ||
| EV to EBITDA | 5.95 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.32% | ||
| Return on Equity | 3.46% | ||
| Operating Margin | 4.49% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 1,080.87 | 1,031.37 | 838.8 | 986.69 | 1,064.86 | n/a | n/a | 4.19% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +30.01 | -15.74 | -32.4 | +57.65 | -42.19 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Shenzhen Neptunus Interlong Bio-technique Co Ltd is a China-based company principally engaged in the research and development, manufacturing and selling of medicines and medical devices, and the purchase and sales of medicines, healthcare food products and medical devices. The Company operates its businesses through two segments. The Manufacturing and Selling of Medicines and Medical Devices segment is mainly engaged in manufacturing, sales of medicines and medical devices. The Sales and Distribution of Medicines, Healthcare Products and Medical Devices segment is mainly engaged in sales and distribution of medicines, healthcare products and medical devices. The Company mainly operates its businesses in the domestic market.
Directors
- Feng Zhang CHM
- Jian Bo Huang GMG (44)
- Man Chao Wang OTH (37)
- Hang Yuan OTH (39)
- Wai Sum Fung SEC
- Ling Xia Mu SEC (46)
- Zhanjun Liu NED
- Ting Jiu Song NED (59)
- Yan He Xu NED (59)
- Lin Yu NED (58)
- Yi Fei Zhang NED (48)
- Wen Liang Zhao NED (40)
- Ka Yeung Poon NID (50)
- Wing Fat Yick NID (62)
- Jian Zhou Zhang NID (46)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- November 15th, 1994
- Public Since
- September 12th, 2005
- No. of Employees
- 1,471
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,678,000,000
- Address
- 1F, Block 1, Research Building, SHENZHEN, 518000
- Web
- https://www.interlong.com/
- Phone
- +86 75526411869
- Auditors
- Grant Thornton Hong Kong Limited
Upcoming Events for 8329
Dividend For 8329.HK - 0.0050 CNY
Dividend For 8329.HK - 0.1410 CNY
Q1 2025 Shenzhen Neptunus Interlong Bio-technique Co Ltd Earnings Release
Shenzhen Neptunus Interlong Bio-technique Co Ltd Annual Shareholders Meeting
Similar to 8329
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Shenzhen Neptunus Interlong Bio-technique Co share price?
As of Today at 22:14 UTC, shares in Shenzhen Neptunus Interlong Bio-technique Co are trading at HK$0.35. This share price information is delayed by 15 minutes.
How has the Shenzhen Neptunus Interlong Bio-technique Co share price performed this year?
Shares in Shenzhen Neptunus Interlong Bio-technique Co last closed at HK$0.35 and the price had moved by +127.27% over the past 365 days. In terms of relative price strength the Shenzhen Neptunus Interlong Bio-technique Co share price has outperformed the FTSE Developed Asia Pacific Index by +129.87% over the past year.
What are the analyst and broker recommendations for Shenzhen Neptunus Interlong Bio-technique Co?
There is no consensus recommendation for this security.
Find out moreWhat is the Shenzhen Neptunus Interlong Bio-technique Co dividend yield?
Shenzhen Neptunus Interlong Bio-technique Co does not currently pay a dividend.
Does Shenzhen Neptunus Interlong Bio-technique Co pay a dividend?
Shenzhen Neptunus Interlong Bio-technique Co does not currently pay a dividend.
When does Shenzhen Neptunus Interlong Bio-technique Co next pay dividends?
Shenzhen Neptunus Interlong Bio-technique Co does not currently pay a dividend.
How do I buy Shenzhen Neptunus Interlong Bio-technique Co shares?
To buy shares in Shenzhen Neptunus Interlong Bio-technique Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Shenzhen Neptunus Interlong Bio-technique Co?
As of the previous close price of HK$0.35, shares in Shenzhen Neptunus Interlong Bio-technique Co had a market capitalisation of HK$570.52m.
Where are Shenzhen Neptunus Interlong Bio-technique Co shares listed?
Here are the trading details for Shenzhen Neptunus Interlong Bio-technique Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 8329
What kind of share is Shenzhen Neptunus Interlong Bio-technique Co?
Based on an overall assessment of its quality, value and momentum Shenzhen Neptunus Interlong Bio-technique Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Shenzhen Neptunus Interlong Bio-technique Co share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Shenzhen Neptunus Interlong Bio-technique Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shenzhen Neptunus Interlong Bio-technique Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +183.11%.
As of the last closing price of HK$0.35, shares in Shenzhen Neptunus Interlong Bio-technique Co were trading +120.79% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Shenzhen Neptunus Interlong Bio-technique Co PE Ratio?
The Shenzhen Neptunus Interlong Bio-technique Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Shenzhen Neptunus Interlong Bio-technique Co?
Shenzhen Neptunus Interlong Bio-technique Co's management team is headed by:
- Feng Zhang - CHM
- Jian Bo Huang - GMG
- Man Chao Wang - OTH
- Hang Yuan - OTH
- Wai Sum Fung - SEC
- Ling Xia Mu - SEC
- Zhanjun Liu - NED
- Ting Jiu Song - NED
- Yan He Xu - NED
- Lin Yu - NED
- Yi Fei Zhang - NED
- Wen Liang Zhao - NED
- Ka Yeung Poon - NID
- Wing Fat Yick - NID
- Jian Zhou Zhang - NID